JPH09322781A5 - - Google Patents

Info

Publication number
JPH09322781A5
JPH09322781A5 JP1997020160A JP2016097A JPH09322781A5 JP H09322781 A5 JPH09322781 A5 JP H09322781A5 JP 1997020160 A JP1997020160 A JP 1997020160A JP 2016097 A JP2016097 A JP 2016097A JP H09322781 A5 JPH09322781 A5 JP H09322781A5
Authority
JP
Japan
Prior art keywords
seq
polynucleotide
isolated polynucleotide
nucleotides
acid sequence
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
JP1997020160A
Other languages
English (en)
Japanese (ja)
Other versions
JPH09322781A (ja
Filing date
Publication date
Application filed filed Critical
Publication of JPH09322781A publication Critical patent/JPH09322781A/ja
Publication of JPH09322781A5 publication Critical patent/JPH09322781A5/ja
Withdrawn legal-status Critical Current

Links

JP2016097A 1996-01-05 1997-01-06 Staphylococcus aureusポリヌクレオチドおよび配列 Withdrawn JPH09322781A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US986196P 1996-01-05 1996-01-05
US60/009,861 1996-01-05

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2003431638A Division JP2004135679A (ja) 1996-01-05 2003-12-25 Staphylococcusaureusポリヌクレオチドおよび配列

Publications (2)

Publication Number Publication Date
JPH09322781A JPH09322781A (ja) 1997-12-16
JPH09322781A5 true JPH09322781A5 (https=) 2004-12-09

Family

ID=21740142

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2016097A Withdrawn JPH09322781A (ja) 1996-01-05 1997-01-06 Staphylococcus aureusポリヌクレオチドおよび配列
JP2003431638A Withdrawn JP2004135679A (ja) 1996-01-05 2003-12-25 Staphylococcusaureusポリヌクレオチドおよび配列

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2003431638A Withdrawn JP2004135679A (ja) 1996-01-05 2003-12-25 Staphylococcusaureusポリヌクレオチドおよび配列

Country Status (4)

Country Link
US (2) US6737248B2 (https=)
EP (1) EP0786519A3 (https=)
JP (2) JPH09322781A (https=)
CA (1) CA2194411A1 (https=)

Families Citing this family (254)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6696561B1 (en) * 1909-07-09 2004-02-24 Basf Aktiengesellschaft Corynebacterium glutamicum genes encoding proteins involved in membrane synthesis and membrane transport
US6251647B1 (en) * 1993-12-06 2001-06-26 The Rockefeller University Auxiliary genes and proteins of methicillin resistant bacteria and antagonists thereof
ES2323161T3 (es) * 1994-06-24 2009-07-08 Innogenetics N.V. Deteccion, identificacion y diferenciacion simultaneas de especies de mycobacterium utilizando un ensayo de hibridacion.
US20020055101A1 (en) 1995-09-11 2002-05-09 Michel G. Bergeron Specific and universal probes and amplification primers to rapidly detect and identify common bacterial pathogens and antibiotic resistance genes from clinical specimens for routine diagnosis in microbiology laboratories
US5994066A (en) * 1995-09-11 1999-11-30 Infectio Diagnostic, Inc. Species-specific and universal DNA probes and amplification primers to rapidly detect and identify common bacterial pathogens and associated antibiotic resistance genes from clinical specimens for routine diagnosis in microbiology laboratories
US6514746B1 (en) 1995-09-15 2003-02-04 Essential Therapeutics, Inc. Staphylococcus aureus histidine protein kinase essential genes
US6037123A (en) 1995-09-15 2000-03-14 Microcide Pharmaceuticals, Inc. Methods of screening for compounds active on Staphylococcus aureus target genes
US5962283A (en) 1995-12-07 1999-10-05 Diversa Corporation Transminases and amnotransferases
US6403337B1 (en) 1996-01-05 2002-06-11 Human Genome Sciences, Inc. Staphylococcus aureus genes and polypeptides
US6833253B2 (en) * 1996-01-05 2004-12-21 Human Genome Sciences, Inc. Staphylococcus aureus polynucleotides and polypeptides
GB9601067D0 (en) * 1996-01-19 1996-03-20 Smithkline Beecham Plc Novel compounds
US6903204B1 (en) * 1996-01-19 2005-06-07 Replidyne, Inc. Polynucleotides encoding methionyl tRNA synthetase from Staphylococcus aureus, related products and methods
WO1997026342A1 (en) * 1996-01-19 1997-07-24 Smithkline Beecham Plc THREONYL-tRNA SYNTHETASE OF STAPHYLOCOCCUS AUREUS
US5756329A (en) * 1996-01-19 1998-05-26 Smithkline Beecham P.L.C. DNA encoding phenylalanyl tRNA synthetase from Staphylococcus aureus
US5882891A (en) 1996-02-20 1999-03-16 Smithkline Beecham Corporation Ferrichrome transport ATP-binding protein
US6010881A (en) 1996-02-20 2000-01-04 Smithkline Beecham Corporation RibG
WO1997030070A1 (en) * 1996-02-20 1997-08-21 Smithkline Beecham Corporation Novel compounds
US5989864A (en) 1996-10-29 1999-11-23 Smithkline Beecham Corporation DNA encoding spo-rel polypeptides
GB9605381D0 (en) * 1996-03-14 1996-05-15 Smithkline Beecham Plc Novel compounds
GB9608000D0 (en) * 1996-04-18 1996-06-19 Smithkline Beecham Plc Novel compounds
GB9607993D0 (en) * 1996-04-18 1996-06-19 Smithkline Beecham Plc Novel compounds
GB9607991D0 (en) * 1996-04-18 1996-06-19 Smithkline Beecham Plc Novel compounds
US6165989A (en) * 1996-05-14 2000-12-26 Smithkline Beecham Corporation Era of Streptococcus pneumoniae
EP0956289A4 (en) 1996-08-16 2004-10-13 Smithkline Beecham Corp NOVEL PROKARYOTA POLYNUCLEOTIDES AND POLYPEPTIDES AND USES THEREOF
DE69735225T2 (de) * 1996-08-28 2006-11-02 Affinium Pharmaceuticals, Inc., Toronto Fab I Enoyl-ACP-Reduktase aus Staphylokokken
US6995254B1 (en) 1996-08-28 2006-02-07 Affinium Pharmaceuticals, Inc. Polynucleotide encoding the enoyl-acyl carrier protein reductase of Staphylococcus aureus, FAB I
US6107071A (en) * 1996-09-24 2000-08-22 Smithkline Beecham Corporation Histidinol dehydrogenase
US6013505A (en) * 1996-10-08 2000-01-11 Smithkline Beecham Corporation Topoisomerase I
US6025156A (en) * 1996-10-15 2000-02-15 Smithkline Beecham Corporation Topoisomerase III
US6348584B1 (en) * 1996-10-17 2002-02-19 John Edward Hodgson Fibronectin binding protein compounds
US5942419A (en) * 1996-10-24 1999-08-24 Smithkline Beecham P.L.C. RsbW-1 encoding nucleic acids
US6310192B1 (en) 1996-10-24 2001-10-30 Smithkline Beecham Corporation SigB
US6004556A (en) * 1996-10-24 1999-12-21 Smithkline Beecham Corporation Staphylococcus aureus RSBU-1
US6020160A (en) * 1996-10-24 2000-02-01 Smithkline Beecham Corporation RsbV-1 polynucleotides of Staphylococcus aureus
US20100267012A1 (en) 1997-11-04 2010-10-21 Bergeron Michel G Highly conserved genes and their use to generate probes and primers for detection of microorganisms
US20030049636A1 (en) 1999-05-03 2003-03-13 Bergeron Michel G. Species-specific, genus-specific and universal DNA probes and amplification primers to rapidly detect and identify common bacterial and fungal pathogens and associated antibiotic resistance genes from clinical specimens for diagnosis in microbiology laboratories
US5827689A (en) * 1996-11-13 1998-10-27 Smithkline Beecham Corporation FabD polynucleotides
EP1329510A3 (en) * 1996-11-13 2003-08-27 SmithKline Beecham Corporation Staphylococcus FabD
US5955304A (en) * 1997-01-02 1999-09-21 Smithkline Beecham Corporation DivIB
US6022706A (en) * 1997-04-09 2000-02-08 Smithkline Beecham Corporation Div1b
US6258934B1 (en) 1997-01-24 2001-07-10 Smithkline Beecham Corporation FabD
CA2279490A1 (en) * 1997-02-03 1998-08-06 Yale University Glutrnagln amidotransferase - a novel essential translational component
US6150340A (en) * 1997-02-07 2000-11-21 Smithkline Beecham Corporation RNA-dependent amidotransferase from Staphylococcus aureus
US6410263B1 (en) * 1997-02-07 2002-06-25 Smithkline Beecham Corporation Histidine kinase
CA2224085A1 (en) * 1997-02-21 1998-08-21 Smithkline Beecham Corporation Aroe
US6210940B1 (en) 1997-04-18 2001-04-03 Smithkline Beecham Corporation Compounds
US6586578B1 (en) 1997-05-21 2003-07-01 Smithkline Beecham Corporation Defl
EP0881285A1 (en) * 1997-05-29 1998-12-02 Smithkline Beecham Corporation D-Alanine transferase
US5891678A (en) * 1997-06-04 1999-04-06 Smithkline Beecham Corporation DNA encoding the SecA1 polypeptide of Staphylococcus aureus
US6204019B1 (en) 1997-06-04 2001-03-20 Smithkline Beecham Corporation Sec A2 from Streptococcus pneumoniae
US5866367A (en) * 1997-07-01 1999-02-02 Smithkline Beecham Corporation Gidb
CA2236435A1 (en) * 1997-07-01 1999-01-01 Smithkline Beecham Corporation Gida2
EP0892055A3 (en) * 1997-07-01 2002-03-20 Smithkline Beecham Corporation GidB polypeptides from Staphylococcus aureus
CA2236452A1 (en) * 1997-07-01 1999-01-01 Smithkline Beecham Corporation Gida1
US6455323B1 (en) 1997-07-03 2002-09-24 Pharmacia & Upjohn Company Anti-bacterial methods and materials
US6838255B1 (en) * 1997-07-03 2005-01-04 Smithkline Beecham Corporation MurC
EP0890644A3 (en) * 1997-07-10 1999-09-29 Smithkline Beecham Corporation MurA gene from Staphylococcus aureus encoding DP-N-Acetylglucosamine enolpyruvyl transferase
US5889171A (en) * 1997-07-18 1999-03-30 Smithkline Beecham Corporation TarF
DE19731292A1 (de) * 1997-07-21 1999-01-28 Biotecon Ges Fuer Biotechnologische Entwicklung & Consulting Mbh Nucleinsäuremolekül, Kit und Verwendung
EP0893500A3 (en) * 1997-07-23 2001-10-17 Smithkline Beecham Corporation BmrU gene from Staphylococcus aureus
EP0916729A3 (en) * 1997-07-23 1999-08-04 Smithkline Beecham Corporation Novel reductase
US5891670A (en) * 1997-07-23 1999-04-06 Smithkline Beecham Corporation Tetracycline resistance protein
US5994096A (en) * 1997-07-25 1999-11-30 Smithkline Beecham Corporation Regulator
EP0896060A3 (en) * 1997-08-08 2000-07-19 Smithkline Beecham Corporation RpoA gene from Staphylococcus aureus
US6258578B1 (en) * 1997-08-11 2001-07-10 Smithkline Beecham Corporation His5
US6335433B1 (en) * 1997-08-11 2002-01-01 Smithkline Beecham Corporation nrdD
US6180387B1 (en) 1997-08-11 2001-01-30 Smithkline Beecham Corporation Arginine deiminase
US6380370B1 (en) * 1997-08-14 2002-04-30 Genome Therapeutics Corporation Nucleic acid and amino acid sequences relating to Staphylococcus epidermidis for diagnostics and therapeutics
US6225098B1 (en) * 1997-08-25 2001-05-01 Smithkline Beecham Corporation UDP-N-acetylenolpyruvyglucosamine reductase
US6274361B1 (en) * 1997-08-26 2001-08-14 Smithkline Beecham Corporation pth
US6331410B1 (en) * 1997-08-29 2001-12-18 Smithkline Beecham Corp. Polynucleotides encoding a novel pyrR homolog
US6124119A (en) * 1997-09-04 2000-09-26 Smithkline Beecham Corporation mecB
US6284515B1 (en) * 1997-09-03 2001-09-04 Smithkline Beecham Corporation Signal recognition particle polypeptides and polynucleotides
US6080729A (en) * 1998-03-17 2000-06-27 Smithkline Beecham Corporation Spo0J2 of Staphylococcus aureus
US5888771A (en) * 1997-09-04 1999-03-30 Smithkline Beecham Corporation Integral membrane proteins from Streptoccus pneumoniae
EP0905233A2 (en) * 1997-09-04 1999-03-31 Smithkline Beecham Corporation Staphylococcus aureus trigger factor
US6524813B1 (en) * 1997-09-04 2003-02-25 Smithkline Beecham Corporation Polynucleotide encoding spo0J1 of Staphylococcus aureus
JP2002511768A (ja) * 1997-09-04 2002-04-16 スミスクライン・ビーチャム・コーポレイション スタフィロコッカス・アウレウスのSpoOJ2
CA2244323A1 (en) * 1997-09-18 1999-03-18 Smithkline Beecham P.L.C. Novel gapdh
EP0905247A3 (en) * 1997-09-25 1999-10-20 Smithkline Beecham Corporation MurF polynucleotides and polypeptides from Staphylococcus
EP0905249A3 (en) * 1997-09-25 1999-08-04 Smithkline Beecham Corporation Alcohol dehydrogenase
US6287807B1 (en) * 1997-09-25 2001-09-11 Smithkline Beecham Corporation MurF
US6013497A (en) * 1997-09-25 2000-01-11 Smithkline Beecham Corporation MurE
JP2001514530A (ja) * 1997-10-03 2001-09-11 スミスクライン・ビーチャム・コーポレイション 新規clpL
JP2001507945A (ja) * 1997-10-03 2001-06-19 スミスクライン・ビーチャム・コーポレイション スタフィロコッカス・アウレウスのリボソームリサイクリングファクター(frr)
US6251629B1 (en) * 1997-10-07 2001-06-26 Smithkline Beecham Corporation ABC transporter
US5989858A (en) * 1997-10-28 1999-11-23 Smithkline Beecham Corporation Dead-type ATP-dependent RNA helicase (DbpB) from Staphylococcus aureus
EP0913474A3 (en) * 1997-10-28 1999-12-29 Smithkline Beecham Corporation Dbpa, a helicase from Staphylococcus aureus
US6346393B1 (en) * 1997-11-06 2002-02-12 Smithkline Beecham Corp. Polynucleotides encoding a ribonuclease s
US6548633B1 (en) 1998-12-22 2003-04-15 Genset, S.A. Complementary DNA's encoding proteins with signal peptides
US6682919B1 (en) * 1997-11-14 2004-01-27 Smithkline Beecham Corporation FabH
US6680195B1 (en) 1997-11-26 2004-01-20 Inhibitex, Inc. Extracellular matrix-binding proteins from staphylococcus aureus
AU1537699A (en) * 1997-11-26 1999-06-15 Bioresearch Ireland a division of Eolas - The Irish Science and Technology Agency Extracellular matrix-binding proteins from (staphylococcus aureus)
AU5903398A (en) * 1997-12-23 1999-07-12 Microcide Pharmaceuticals, Inc. Staphylococcus aureus histidine protein kinase essential genes
AU1726199A (en) 1997-12-31 1999-07-19 Chiron Corporation Metastatic cancer regulated gene
US7432365B1 (en) 1998-01-27 2008-10-07 O'donnell Michael E DNA molecules encoding beta clamp proteins of gram positive bacteria
AU2341699A (en) * 1998-01-27 1999-08-09 Rockefeller University, The Dna replication proteins of gram positive bacteria and their use to screen for chemical inhibitors
AU764441B2 (en) 1998-02-09 2003-08-21 Genset S.A. cDNAs encoding secreted proteins
US6448037B1 (en) * 1998-02-20 2002-09-10 Smithkline Beecham Corporation PgsA
US6767536B1 (en) * 1998-03-02 2004-07-27 Ramot At Tel Aviv University Ltd. Recombinant Staphylococcus thioredoxin reductase and inhibitors thereof useful as antimicrobial agents
WO1999045123A1 (en) * 1998-03-02 1999-09-10 Abbott Laboratories Recombinant staphylococcus thioredoxin reductase, and inhibitors thereof useful as antimicrobial agents
US6083924A (en) * 1998-03-12 2000-07-04 Smithkline Beecham Corporation DnaB of staphylococcus aureus
US6555338B1 (en) * 1998-03-17 2003-04-29 Smithkline Beecham Corporation NrdF from Staphylococcus aureus
US6287804B1 (en) * 1998-03-17 2001-09-11 Smithkline Beecham Corporation nrdG
GB9806762D0 (en) * 1998-03-31 1998-05-27 Neutec Pharma Plc Treatment and diagnosis of staphylococcal infections
EP2261352A3 (en) * 1998-05-01 2012-01-04 Novartis Vaccines and Diagnostics, Inc. Neisseria meningitidis antigens and compositions
US6468743B1 (en) * 1998-05-18 2002-10-22 Conagra Grocery Products Company PCR techniques for detecting microbial contaminants in foodstuffs
US6117662A (en) * 1998-05-22 2000-09-12 Smithkline Beecham Corporation Respiratory nitrate reductase alpha subunit
WO1999065530A1 (en) * 1998-06-17 1999-12-23 Smithkline Beecham Corporation NrdD
WO1999067360A2 (en) * 1998-06-25 1999-12-29 Hemosol Inc. Media and methods for expansion of erythroid stem cells for the production of hemoglobin
WO2000001801A1 (en) * 1998-07-02 2000-01-13 Smithkline Beecham Corporation Ftsz multimeric proteins and their uses
US6222014B1 (en) * 1998-08-10 2001-04-24 Smithkline Beecham Corporation NrdE of staphylococcus aureus
AU5582799A (en) * 1998-08-25 2000-03-14 Schering Corporation Staphylococcus aureus polypeptides
US20020092987A1 (en) * 1998-09-05 2002-07-18 Taehee Cho Photo detect device using quantum dots and materialization method thereof
US6222026B1 (en) * 1998-09-08 2001-04-24 Smithkline Beecham Corporation Gcp
US6110723A (en) * 1998-11-12 2000-08-29 Smithkline Beecham Corporation Yfii pseudouridine synthase
US7101969B1 (en) 1998-12-03 2006-09-05 Targanta Therapeutics Compositions and methods involving an essential Staphylococcus aureus gene and its encoded protein
US6982153B1 (en) 1998-12-03 2006-01-03 Targanta Therapeutics, Inc. DNA sequences from staphylococcus aureus bacteriophage 77 that encode anti-microbial polypeptides
US6451556B1 (en) 1998-12-21 2002-09-17 Smithkline Beecham Corporation EF-Tu
US6448038B1 (en) * 1999-01-26 2002-09-10 Smithkline Beecham Corporation BirA from staphylococcus aureus
WO2000044765A1 (en) * 1999-01-27 2000-08-03 Smithkline Beecham Corporation Mvk
US6720139B1 (en) 1999-01-27 2004-04-13 Elitra Pharmaceuticals, Inc. Genes identified as required for proliferation in Escherichia coli
US6352840B1 (en) 1999-02-01 2002-03-05 Smithkline Beecham Corporation pskG
WO2000050433A2 (en) * 1999-02-26 2000-08-31 Smithkline Beecham Corporation Staphylococcus aureus q13 polynucleotides, polypeptides and methods of use
WO2000056865A1 (en) * 1999-03-22 2000-09-28 Smithkline Beecham Corporation Histidine kinase
US6107058A (en) * 1999-03-26 2000-08-22 Smithkline Beecham Corporation ispA from Staphylococcus aureus
WO2000058331A1 (en) * 1999-03-26 2000-10-05 Smithkline Beecham Corporation Mvd
WO2000058441A1 (en) * 1999-03-26 2000-10-05 Smithkline Beecham Corporation STAPHYLOCOCCUS AUREUS ydjB RELATED TO THE LUXS AUTOINDUCER SYNTHESIS FAMILY
WO2000059918A1 (en) * 1999-04-07 2000-10-12 University Of Utah Research Foundation EUBACTERIAL tmRNA SEQUENCES AND USES THEREOF
WO2000061778A1 (en) * 1999-04-13 2000-10-19 Smithkline Beecham Corporation Staphylococcus aureus mvaa
CA2365523A1 (en) 1999-04-15 2000-10-26 The Regents Of The University Of California Identification of sortase gene
US7101692B2 (en) 1999-04-15 2006-09-05 The Regents Of The University Of California Identification of sortase gene
EP1173560A1 (en) * 1999-04-30 2002-01-23 Hybrigenics S.A. Collection of prokaryotic dna for two hybrid systems helicobacter pylori protein-protein interactions and application thereof
ATE335847T1 (de) * 1999-05-03 2006-09-15 Gen Probe Inc Poynukleotidsonden zur exklusiven detektion und quantifizierung von staphylococcus
US6821770B1 (en) 1999-05-03 2004-11-23 Gen-Probe Incorporated Polynucleotide matrix-based method of identifying microorganisms
WO2000071568A1 (en) * 1999-05-04 2000-11-30 Smithkline Beecham Corporation Staphylococcal ica operon
AU5561599A (en) * 1999-05-05 2000-11-21 Sterrenbeld Biotechnologie North America, Inc. Dna promoter sequence for gene expression
WO2000067780A1 (en) * 1999-05-06 2000-11-16 Smithkline Beecham Corporation Methods of modulating fabh activity
WO2000068140A1 (en) * 1999-05-06 2000-11-16 Smithkline Beecham Corporation Signal transduction response regulator family of staphylococcus
US6194174B1 (en) * 1999-05-12 2001-02-27 Smithkline Beecham Corporation Histidine kinase, 636 HK, of staphylococcus aureus
US6489139B1 (en) * 1999-06-24 2002-12-03 Smithkline Beecham Corporation FabZ from Staphylococcus aureus
KR100878332B1 (ko) * 1999-06-25 2009-01-14 백광산업 주식회사 막 합성 및 막 운반 관련 단백질을 코딩하는코리네박테리움 글루타미쿰 유전자
KR20070087089A (ko) * 1999-06-25 2007-08-27 바스프 악티엔게젤샤프트 탄소 대사 및 에너지 생산과 관련된 단백질을 코딩하는코리네박테리움 글루타미쿰 유전자
JP2003523175A (ja) 1999-08-04 2003-08-05 ファルマシア・アンド・アップジョン・カンパニー スタフィロコッカスアウレウスUDP−N−アセチルエノールピルビルグルコサミン=リダクターゼ(S.aureusMurB)の結晶化および構造決定
CA2378010A1 (en) * 1999-08-04 2001-02-15 Pharmacia & Upjohn Company Crystallization and structure determination of staphylococcus aureus thymidylate kinase
US6689595B1 (en) 1999-08-04 2004-02-10 Pharmacia & Upjohn Company Crystallization and structure determination of Staphylococcus aureus thymidylate kinase
JP2003510025A (ja) * 1999-08-06 2003-03-18 スミスクライン・ビーチャム・コーポレイション Map
US6294357B1 (en) 1999-08-31 2001-09-25 Smithkline Beecham Corporation FabF from Staphylococcus aureus
AU7337000A (en) * 1999-09-01 2001-03-26 Human Genome Sciences, Inc. 37 staphylococcus aureus genes and polypeptides
WO2001018249A1 (en) * 1999-09-10 2001-03-15 Smithkline Beecham Corporation Staphylococcus aureus kdtb polynucleotide and polypeptide
US6197546B1 (en) * 1999-09-20 2001-03-06 Smithkline Beecham Corporation PcrA Helicase of Staphylococcus aureus
WO2001023403A1 (en) * 1999-09-27 2001-04-05 Smithkline Beecham Corporation ypga CLADE GENES
WO2001023418A1 (en) * 1999-09-28 2001-04-05 Smithkline Beecham Corporation YphC
EP1246935B1 (en) 1999-09-28 2013-08-14 Geneohm Sciences Canada Inc. Highly conserved genes and their use to generate probes and primers for detection of microorganisms
US6951729B1 (en) 1999-10-27 2005-10-04 Affinium Pharmaceuticals, Inc. High throughput screening method for biological agents affecting fatty acid biosynthesis
WO2001030806A1 (en) * 1999-10-28 2001-05-03 Smithkline Beecham Corporation Polynucleotides and polypeptides involved in biofilm biology and their uses
WO2001032022A1 (en) * 1999-11-04 2001-05-10 Smithkline Beecham Corporation YtgP
WO2001034810A2 (en) 1999-11-09 2001-05-17 Elitra Pharmaceuticals, Inc. Genes essential for microbial proliferation
WO2001038345A1 (en) * 1999-11-24 2001-05-31 Smithkline Beecham Corporation Regulatable fabh constructs
KR20020073150A (ko) * 1999-12-23 2002-09-19 브이맥스 리미티드 독성 유전자, 단백질, 및 그 용도
RU2240327C2 (ru) * 1999-12-23 2004-11-20 Вмакс Лимитед Ген и белок вирулентности и их использование
US6316211B1 (en) 2000-01-26 2001-11-13 Smithkline Beecham Corporation ThdF
JPWO2001055397A1 (ja) * 2000-01-28 2004-01-08 平松 啓一 新規ポリペプチドVraS及びVraR
JP2005229801A (ja) * 2000-01-28 2005-09-02 Keiichi Hiramatsu 新規ポリペプチドHmrA及びHmrB
US6988041B2 (en) * 2000-01-31 2006-01-17 Pharmacia & Upjohn Company Crystallization and structure determination of Staphylococcus aureus NAD synthetase
EP1257561A4 (en) * 2000-02-24 2004-09-29 Anadys Pharmaceuticals Inc STAPHYLOKKOKE GTPASE OBG CLEOTIDE SEQUENCE ENCODING STAPHYLOKKOKES GTP BINDING PROTEIN
WO2001064855A1 (en) * 2000-03-01 2001-09-07 Smithkline Beecham Corporation Clpp
US6764823B2 (en) 2000-04-06 2004-07-20 Pharmacia & Upjohn Company Antimicrobial methods and materials
AU2001274412A1 (en) * 2000-05-19 2001-11-26 Institut National De La Sante Et De La Recherche Medicale (Inserm) Methods for detecting and identifying a gram positive bacteria in a sample
GB0014907D0 (en) 2000-06-20 2000-08-09 Univ Sheffield Antigenic polypeptides
US6864080B2 (en) 2000-06-30 2005-03-08 Pharmacia & Upjohn Company Crystallization and structure of Staphylococcus aureus peptide deformylase
AU2001269527A1 (en) * 2000-07-18 2002-01-30 Center For Advanced Science And Technology Incubation, Ltd. Isopentenyl pyrophosphate isomerase
WO2002008265A2 (en) * 2000-07-19 2002-01-31 Pharmacia & Upjohn Company Staphylococcus aureus ribosomal protein s20, corresponding gene and methods for the identification of antibacterial substances
EA013564B1 (ru) * 2000-08-03 2010-06-30 Терапеутик Хьюман Поликлоналз Инк. Гуманизированный иммуноглобулин и содержащая его фармацевтическая композиция
SE0003573D0 (sv) * 2000-10-04 2000-10-04 Bengt Guss Method and means for producing novel von Willebrand factor binding proteins and their use in biotechnology
US8168773B2 (en) 2000-10-06 2012-05-01 Novozymes, Inc. Methods for monitoring multiple gene expression
US7048926B2 (en) 2000-10-06 2006-05-23 Affinium Pharmaceuticals, Inc. Methods of agonizing and antagonizing FabK
WO2002050545A2 (en) 2000-12-19 2002-06-27 Phagetech Inc. Compositions and methods involving staphylococcus aureus protein staau-r9
AT410798B (de) 2001-01-26 2003-07-25 Cistem Biotechnologies Gmbh Verfahren zur identifizierung, isolierung und herstellung von antigenen gegen ein spezifisches pathogen
EP1227152A1 (en) * 2001-01-30 2002-07-31 Société des Produits Nestlé S.A. Bacterial strain and genome of bifidobacterium
GB0107661D0 (en) 2001-03-27 2001-05-16 Chiron Spa Staphylococcus aureus
CA2348042A1 (en) 2001-06-04 2002-12-04 Ann Huletsky Sequences for detection and identification of methicillin-resistant staphylococcus aureus
JP4424984B2 (ja) * 2001-06-15 2010-03-03 インヒビテックス インコーポレーテッド コアグラーゼ陰性ブドウ球菌および黄色ブドウ球菌由来の表面蛋白質を認識する、交差反応性モノクローナルおよびポリクローナル抗体
AU2002328215A1 (en) * 2001-09-18 2003-04-01 Affinium Pharmaceuticals, Inc. Purified bacterial polypeptides involved in nucleic acid processing
US20050214773A1 (en) * 2001-09-21 2005-09-29 Affinium Pharmaceuticals, Inc. Novel purified polypeptides from bacteria
WO2003025005A2 (en) * 2001-09-21 2003-03-27 Affinium Pharmaceuticals, Inc. Purified bacterial polypeptides involved in protein processing
FR2831187A1 (fr) * 2001-10-22 2003-04-25 Univ Aix Marseille Ii Methode de determination de l'activite bacteriostatique ou bactericide des agents antibiotiques par pcr quantitative
US20040029129A1 (en) * 2001-10-25 2004-02-12 Liangsu Wang Identification of essential genes in microorganisms
AU2002363925A1 (en) * 2001-11-29 2003-06-17 Wyeth Holdings Corporation ALLOIOCOCCUS OTITIDIS OPEN READING FRAMES (ORFs) ENCODING POLYPEPTIDE ANTIGENS, IMMUNOGENIC COMPOSITIONS AND USES THEREOF
AU2003202378A1 (en) * 2002-02-04 2003-09-02 Affinium Pharmaceuticals, Inc. Novel purified polypeptides from staphylococcus aureus
US6946267B2 (en) * 2002-03-13 2005-09-20 Dr. Chip Biotechnology Inc. Method for detecting Staphylococcus aureus
WO2003084986A2 (en) * 2002-04-04 2003-10-16 Affinium Pharmaceuticals, Inc. Novel purified polypeptides involved in cellular metabolism
WO2004009839A2 (de) * 2002-07-18 2004-01-29 Henkel Kommanditgesellschaft Auf Aktien Obligonukleotide zum nachweis von mikroorganismen
AU2003257470A1 (en) * 2002-07-18 2004-02-09 Henkel Kommanditgesellschaft Auf Aktien Detection of microorganisms
JPWO2004020635A1 (ja) * 2002-08-28 2005-12-15 株式会社テクノネットワーク四国 バクテリオファージおよび細菌感染症治療剤
AU2003289984A1 (en) * 2002-12-06 2004-06-30 Innogenetics N.V. Detection, identification and differentiation of eubacterial taxa using a hybridization assay
DK1641926T3 (da) * 2003-07-08 2011-06-27 Umc Utrecht Holding Bv Terapeutisk anvendelse af LPI, en stafylokokal lectinstiinhibitor ved inflammatoriske sygdomme
FR2857375B1 (fr) * 2003-07-10 2007-11-09 Biomerieux Sa Procede de detection et/ou d'identification de bacteries de genre staphylococcus
CA2532024A1 (en) 2003-07-11 2005-01-20 Affinium Pharmaceuticals, Inc. Novel purified polypeptides from staphylococcus aureus
WO2005059165A2 (en) 2003-12-09 2005-06-30 Biomerieux, Inc. Methods for detecting bacterial pathogens
EP1692512B1 (en) 2003-12-09 2012-09-05 bioMérieux, Inc. Methods for detecting bacterial pathogens
WO2005056817A2 (en) 2003-12-09 2005-06-23 Biomerieux, Inc. Method for recovering microorganisms from a sample
AU2005214061B2 (en) 2004-02-18 2010-02-04 Merck Sharp & Dohme Corp. Polypeptides for inducing a protective immune response against Staphylococcus aureus
GB0409559D0 (en) * 2004-04-29 2004-06-02 Univ Sheffield Polypeptide
US20080095792A1 (en) * 2004-09-17 2008-04-24 Anderson Annaliesa S Polypeptides For Inducing A Protective Immune Response Against Staphylococcus Aureus
AU2005287145A1 (en) * 2004-09-17 2006-03-30 Merck & Co., Inc. Polypeptides for inducing a protective immune response against Staphylococcus aureus
KR20070058631A (ko) 2004-09-22 2007-06-08 글락소스미스클라인 바이오로지칼즈 에스.에이. 면역원성 조성물
AU2006206577B2 (en) 2005-01-21 2012-03-08 Merck Sharp & Dohme Corp. Polypeptides for inducing a protective immune response against Staphylococcus aureus
DE602006018586D1 (de) * 2005-02-07 2011-01-13 Gen Probe Inc Zusammensetzungen und verfahren zum nachweis von streptokokken der gruppe b
CA2606253A1 (en) * 2005-04-21 2006-10-26 Uti Limited Partnership Pcr for mrsa sccmec typing
US11834720B2 (en) * 2005-10-11 2023-12-05 Geneohm Sciences, Inc. Sequences for detection and identification of methicillin-resistant Staphylococcus aureus (MRSA) of MREJ types xi to xx
WO2007100580A2 (en) * 2006-02-22 2007-09-07 The Texas A & M University System Antibodies recognizing a highly expressed putative antigen of ca-mrsa and methods of use
MY148405A (en) 2006-03-30 2013-04-30 Glaxosmithkline Biolog Sa Immunogenic composition
BRPI0710889A2 (pt) * 2006-04-24 2011-08-16 Sigma Alimentos Sa De Cv método para a detecção e quantificação múltipla e simultánea de patogênicos mediante a reação em cadeia da polimerasa em tempo real
AU2007249286B2 (en) * 2006-05-12 2013-06-13 Gen-Probe Incorporated Compositions and methods to detect enterococci nucleic acid
WO2007137288A2 (en) * 2006-05-23 2007-11-29 Tufts University Methods and compositions for the treatment and prevention of staphylococcus aureus infections through interference with opuc operon interaction with trap
ATE536374T1 (de) 2006-09-01 2011-12-15 Therapeutic Human Polyclonals Inc Erhöhte expression von humanem oder humanisiertem immunglobulin bei nicht-humanen transgenen tieren
EP2074229A4 (en) * 2006-10-13 2011-01-05 Univ Laval RELIABLE PROOF OF VANCOMYCIN INTERMEDIARY STAPHYLOCOCCUS AUREUS
WO2008084889A1 (en) * 2007-01-08 2008-07-17 Medigenes Co., Ltd Dna chip for detection of staphylococcus aureus
WO2008129428A2 (en) 2007-04-19 2008-10-30 Molecular Detection Inc. Methods, compositions and kits for detection and analysis of antibiotic-resistant bacteria
EP2185190B1 (en) * 2007-08-31 2015-06-24 University Of Chicago Methods and compositions related to immunizing against staphylococcal lung diseases and conditions
US9181329B2 (en) 2007-08-31 2015-11-10 The University Of Chicago Methods and compositions related to immunizing against Staphylococcal lung diseases and conditions
WO2009082398A1 (en) * 2007-12-21 2009-07-02 University Of Notre Dame Du Lac Antibacterial compounds and methods of using same
RU2010144789A (ru) * 2008-04-01 2012-05-10 Метаметрикс Клиникал Лэборетери (Us) Процесс и способ мониторинга желудочно-кишечной микрофлоры
WO2010014304A1 (en) * 2008-07-29 2010-02-04 University Of Chicago Compositions and methods related to staphylococcal bacterium proteins
US8318180B2 (en) * 2008-09-30 2012-11-27 University Of Maryland, Baltimore Protective vaccine against Staphylococcus aureus biofilms comprising cell wall-associated immunogens
US9175353B2 (en) 2008-11-14 2015-11-03 Gen-Probe Incorporated Compositions, kits and methods for detection of campylobacter nucleic acid
CN102292105A (zh) 2008-11-26 2011-12-21 默沙东公司 用于诱导抗金黄色葡萄球菌的保护性免疫应答的多肽
AU2009319947A1 (en) 2008-11-26 2010-06-03 Merck Sharp & Dohme Corp. Polypeptides for inducing a protective immune response against Staphylococcus aureus
ES2784957T3 (es) 2009-04-03 2020-10-02 Univ Chicago Composiciones y métodos relacionados con variantes de la proteína A (SPA)
HUE036372T2 (hu) 2009-06-22 2018-07-30 Wyeth Llc Staphylococcus aureus antigének immunogén készítményei
JP2013523818A (ja) 2010-04-05 2013-06-17 ザ・ユニバーシティー・オブ・シカゴ 免疫反応のエンハンサーとしてのプロテインA(SpA)抗体に関連する組成物および方法
JP6002128B2 (ja) 2010-07-02 2016-10-05 ザ・ユニバーシティ・オブ・シカゴThe University Of Chicago プロテインA(SpA)変種に関連する組成物および方法
EP2593133A4 (en) 2010-07-13 2014-11-26 Merck Sharp & Dohme STAPHYLOCOCCUS AUREUS SURFACE PROTEIN SA1789 AND PROTECTIVE VACCINE BASED ON IT
US9095540B2 (en) 2010-09-09 2015-08-04 The University Of Chicago Methods and compositions involving protective staphylococcal antigens
EP2638058B1 (en) 2010-11-12 2017-01-11 Merck Sharp & Dohme Corp. Enolase peptide conjugate vaccines against staphylococcus aureus
US9085631B2 (en) * 2011-04-08 2015-07-21 Nov Vac APS Proteins and nucleic acids useful in vaccines targeting Staphylococcus aureus
US8945588B2 (en) 2011-05-06 2015-02-03 The University Of Chicago Methods and compositions involving protective staphylococcal antigens, such as EBH polypeptides
AU2013252883B2 (en) 2012-04-26 2018-05-17 University Of Chicago Staphylococcal coagulase antigens and methods of their use
WO2014011645A1 (en) 2012-07-10 2014-01-16 Merck Sharp & Dohme Corp. Protective vaccine based on staphylococcus aureus sa2493 protein
US9777274B2 (en) 2013-03-15 2017-10-03 Techulon Inc. Antisense molecules for treatment of staphylococcus aureus infection
SG11201702398UA (en) 2014-09-25 2017-04-27 Univ Notre Dame Du Lac Non-beta lactam antibiotics
WO2017127731A1 (en) * 2016-01-21 2017-07-27 T2 Biosystems, Inc. Nmr methods and systems for the rapid detection of bacteria
WO2018049404A1 (en) 2016-09-12 2018-03-15 University Of Notre Dame Du Lac Compounds for the treatment of clostridium difficile infection
US11572591B2 (en) 2017-04-26 2023-02-07 The Translational Genomics Research Institute Methods and assays for subtyping Staphylococcus aureus clonal complex 8 strains
WO2018200887A1 (en) * 2017-04-26 2018-11-01 The Translational Genomics Research Institute Methods and assays for subtyping staphylococcus aureus clonal complex 8 strains
JP7460531B2 (ja) 2017-12-05 2024-04-02 バイオピーエルエックス,インコーポレイティド 微生物感染を防ぐための方法および組成物
MX2021013833A (es) 2019-05-14 2022-03-17 Univ Chicago Metodos y composiciones que comprenden variantes de la proteina a de estafilococos (spa).
EP3979829A4 (en) * 2019-06-06 2023-06-28 Tata Consultancy Services Limited System and method for combating pseudomonas aeruginosa and staphylococcus aureus infrctions
EP3986118A4 (en) 2019-06-19 2023-10-04 Pioneer Hi-Bred International, Inc. COMPOSITIONS AND METHODS FOR IMPROVING CUSH BREAK TOLERANCE IN RAPS
WO2021051136A1 (en) 2019-09-13 2021-03-18 The University Of Chicago Methods and compositions for treating staphylococcal infections
CN110982757B (zh) * 2019-12-30 2021-04-06 浙江工业大学 阴沟肠杆菌zjph1903及应用
KR102691617B1 (ko) * 2021-12-08 2024-08-13 대한민국 작물의 초형을 조절하는 OsHDSTART1 유전자 및 이의 용도
CN116024371B (zh) * 2022-11-28 2024-12-13 迪飞医学科技(南京)有限公司 一种多重qPCR检测病原菌的引物探针组、试剂盒和检测方法

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5187775A (en) 1990-03-15 1993-02-16 Dnastar, Inc. Computer representation of nucleotide and protein sequences
US5292874A (en) 1991-09-04 1994-03-08 Gen-Probe Incorporated Nucleic acid probes to Staphylococcus aureus
US6037123A (en) * 1995-09-15 2000-03-14 Microcide Pharmaceuticals, Inc. Methods of screening for compounds active on Staphylococcus aureus target genes

Similar Documents

Publication Publication Date Title
JPH09322781A5 (https=)
JP2002510494A5 (https=)
Waters et al. The tetracycline resistance determinants of RP1 and Tn l721: nucleotide sequence analysis
JP2004524824A5 (https=)
CA2337100A1 (en) Polypeptides of lymphodendritic cell adhesion molecules (ldcams) and polynucleotides encoding the same
JP2001520886A5 (https=)
JPH06292593A (ja) Crm蛋白質およびジフテリアトキシンを産生させるための新規なプラスミド
RU98118319A (ru) Гены рецептора трансферрина moraxella
JP2002516103A5 (https=)
DE20251T1 (de) Dns-transfer-vektor, damit transformierter wirt, impfstoff und ihre herstellung.
WO2001070174A3 (en) Vegf-modulated genes and methods employing them
JP2009540801A5 (https=)
CA2385325A1 (en) Chlamydia antigens and corresponding dna fragments and uses thereof
JP2005509420A5 (https=)
CA2215328A1 (en) Novel human cytomegalovirus dna sequences
JP2002517193A5 (https=)
JP2008545393A5 (https=)
JP3751883B2 (ja) ヒトインターフェロンアルファの発現分泌ベクターおよびそれを用いたヒトインターフェロンアルファの生産方法
AU704594B2 (en) Production of recombinant peptides as natural hydrophobic peptide analogues
AU743165B2 (en) Live attenuated bacteria of the species Actinobacillus pleuropneumoniae
JP2004532037A5 (https=)
Pring-kerblom et al. The hexon genes of adenoviruses of subgenus C: comparison of the variable regions
US6605287B2 (en) Vaccines for Chlamydia psittaci infections
CA2241786A1 (en) Novel amp activated protein kinase
JP2003507029A5 (https=)